On October 24th, the 11th China Medical Device Summit Forum (DeviceChina 2021) hosted by BioBAY officially opened in Suzhou Industrial Park. The conference, with the theme of "Based on Industry Trends, Driving National Medical Device Innovation", provides a multidimensional interpretation of the current development of China's medical device industry. From policies and regulations to clinical research, from cutting-edge technologies to investment and mergers and acquisitions, multiple hot topics of discussion in various industries are presented in rotation at the conference.

As a global innovative enterprise focused on continuous glucose monitoring (CGM) product technology, Infinovo Medical was invited to attend the DeviceChina2021 Summit, where its new real-time continuous glucose monitoring system (CGMS), Gu Dekang, participated ™ GN-I made its debut.

At the opening ceremony of this forum, the sixth phase of Suzhou Biomedical Industry Park - Medical Device Industry Park was officially launched. Cheng Rongen, founder of Infinovo Medical, participated in the signing ceremony. As one of the first eight companies to sign contracts in the forefront of high-value consumables, Infinovo Medical has a contracted enterprise area of 20000 square meters. It is expected to build the world's first fully automated production line based on dehydrogenase technology and printing technology by 2023, with a designed production capacity of 12 million pieces per year. At that time, Infinovo Medical is expected to become the world's first CGM commercial mass production enterprise based on dehydrogenase technology.

In the field of diabetes management and nursing, Infinovo Medical has mastered the core technology of continuous glucose monitoring (CGM), and the new generation of continuous glucose monitoring system (CGMS) has achieved a revolutionary breakthrough in the field of blood glucose monitoring.

Infinovo Medical co-founder Wang Junzhe introduced the company's independently developed innovative revolutionary product: the new real-time continuous glucose monitoring system (CGMS) by Gu Dekang ™ GN-I。 This product can achieve continuous glucose monitoring for up to 14 days, with stable performance and high monitoring accuracy (MARD=9.38%). It is a professional version of CGMS product launched by Infinovo for domestic medical institutions. At the same time, the product is simple to operate, meeting the needs of home use, making the blood glucose management of diabetes patients more intelligent, accurate and convenient. Infinovo Medical is committed to improving the life of diabetes patients at any time and in any situation with innovative CGM product technology.

DeviceChina2021

As a high-end conference hosted by BioBAY that focuses on innovative development in the medical device industry in China, the China Medical Device Summit Forum (DeviceChina) has been held since 2011, attracting numerous well-known medical device practitioners, medical experts, entrepreneurs, investors, and senior managers of multinational corporations from home and abroad, gradually expanding its influence.

The 11th China Medical Device Summit Forum (DeviceChina2021) with the theme of "Based on Industry Trends, Driving National Device Innovation" was held on October 24-25 by Jinji Lake in Suzhou.